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Global Problems from Exposure to Asbestos
by Arthur L. Frank
Considerablehuman-deriveddataaboutthehealthconsequences ofasbestosexposureareavailable.Usually,
less information isavailable fromlaboratory modelsofasbestos-related healtheffects.Animal datamirrorthe
experience in man, and cellular studies help in to understand the mechanistic changes related to asbestos.
Although it is clearly carcinogenic, asbestos has shown much variability when examined for its mutagenic
activity. Asbestos, acommercial termreferringto afamilyofsixnaturally occurringmineral fibers, hasbeen
widely used around the world. Disease has been recognized into the last century, and at this time every
occupational group that hasbeenexaminedforpossible asbestos-related disease has demonstrated it. Disease
associated withasbestos makes nodistinction basedon raceorgeography, andwherever asbestos is handled it
produces disease. With shifting global commercial patterns, disease patterns can be expected to shift also.
Human Disease Patterns
Major industrial use of asbestos goes back to the 19th
century, and the fibrotic lung disease caused by exposure
was noted in the 19th century (1).Within the first three
decades of the 20th century, the disease had been more
widely recognized, insurance policies for some asbestos-
exposed workers were no longerwritten, and the disease
asbestosis was given its scientific name. Asbestosis was
added to the growing list of pneumoconioses as first
describedbyZenkerin1867(2).Theoriginaldescriptionof
the process by which dusts damaged the lungs and sur-
rounding tissue took note of both the parenchymal and
pleuralchangesinducedbyexogenousmaterials.Asbestos
exposurewas soon seen to fitthe model as put forth byits
first proponent.
In the mid-1930s, the first suggestion was made that
asbestos exposure could lead to the development of lung
cancer (3), and in the early 1940s Hueper (4) believed that
asbestos could be properly addressed as an occupational
lung carcinogen. It was in this era that efforts were
undertaken for the first time, as documented by subse-
quentreviewers, tomislead scientific andregulatoryinter-
ests regarding thepotential health effects ofasbestos (5).
The uses of asbestos became numerous, and at one time
asbestos had several thousand uses. There is at present,
however, a series ofefforts in the long-time industrialized
nations oftheworld to reduce or entirelyeliminate the use
of asbestos in modern society. Contrasting with this is a
shift in use patterns in the world (6).
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It is now clear that asbestos-related disease in humans
is well understood and in many ways incontrovertable,
although there are still some areas of controversy, and
important questions ofmechanism and related issues are
stillunsettled (7).However,sufficientinformationisunder-
stood to deal with asbestos as the public health problem
thatitrepresents.Thereissomethingrathercuriousabout
the state of knowledge of human disease and asbestos
exposure; more is appreciated about human exposure and
disease than is generally known about the effects of
asbestos in animal or cell culture systems. While not
unique, given the experiencewith tobacco, this-knowledge
base is unusual.
Asbestos hasbeen describedmineralogically as agroup
ofsixrelatedminerals dividedintotwogroups,the serpen-
tine group represented by chrysotile, and the amphibole
group represented by croccidolite, amosite, anthophyllite,
actinolite, and tremolite. All commercially produced fiber
types have been shown to produce disease in man. The
disease patterns can be classified as nonmalignant dis-
eases and malignant diseases.
The nonmalignantproblems related to asbestos include
the relatively inconsequential problem of asbestos warts;
theearliestoftheserious asbestosproblemsintermsofits
appearance afterfirst exposure, benign asbestotic pleural
effusion; and asbestosis, representing the nonmalignant
medical conditions associated with exposure. For
asbestosis, it appears that the disease in all of its man-
ifestations is one that is dose related. Smoking, although
not causing the disease, appears to have some role in
altering the biologic response of an individual, mostly
related to the profusion of changes on chest radiographs
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and complicating pulmonary function testing. Traditional
understanding of pulmonary function changes, which do
not appear to be at all well correlated with radiographic
appearance, would lead one to think that restrictive
changes are associated with asbestosis, although there
havebeen suggestions ofobstructive change aswell. Even
pleural change by itself has been suggested as being
capable of producing some diminution as measured by
pulmonary function test results. The traditional clinical
correlates of dry rales or clubbed fingers are not useful
clinical signs in that they occur in a small percentage of
cases. Although consistentwith the disease processwhen
present, the absence of these symptoms does not negate
the diagnosis ofasbestosis,whichcanbemadeonthebasis
of a history of exposure and an appropriately altered
X-ray. Obviously, tissue confirmation is rarely available.
Malignancyand asbestos exposure havebeenlinkedfor
some50years. Themostimportantmalignancyassociated
with asbestos intermsofbeingacauseofexcessmortality
is of lung cancer. The classic interaction and synergistic
effect of smoking with asbestos exposure is now well
appreciated (8). All commercial fiber types are associated
with human lung cancer.
Asbestos exposure is well recognized as the current,
major identifiable cause of mesothelioma, a usually rare
tumor that was little appreciated before the 20th century.
Members ofboth fiber groups, the serpentine and amphi-
bole groups, can cause this rare and difficult-to-treat
disease. There is controversy with regard to chrysotile
and mesothelioma, but the controversy is not well sup-
ported by the preponderance of scientific evidence from
human and animal studies.
Also controversial is the role ofasbestos in avariety of
gastrointestinal tractcancers. However,ifoneapproaches
this problem by askingwhat is the best available evidence
to address this issue, it seems incontrovertible that
asbestos exposure, as illustrated by the experience of a
cohort of 17,800 asbestos insulation workers who have
been followed to this date from the early 1960s, clearly
demonstrates an excess of a variety of gastrointestinal
cancers (9). Other cancers that have also been suggested
asbeingassociatedwithasbestos exposureincludekidney
cancer and pharyngeal cancers, and the evidence regard-
ing laryngeal cancer is also quite strong. Laryngeal can-
cer has been recognized in several U.S. government
documents as being related to asbestos exposure (10).
There are currently many scientific issues related to
asbestos exposure and the developmentofhuman disease.
From apublichealth perspective, itshouldbenotedthatin
every population investigated that has had documentable
evidence ofasbestos exposurethere appears tobedisease,
that diseases of all types appear to be dose related, and
thatthere appears tobe no geographic orracial alteration
in the basic disease process. Studies in the United States
lookingatethnicdifferencesintermsofthe.developmentof
disease have proven negative. Women as well as men can
develop asbestos-related disease, and the difference in
diseasepatterns reflects differences inexposure histories.
Animal and in Vitro Studies
The studyofdisease in nonhuman experimental models
is an invaluable modalityfor some aspects ofunderstand-
ing the natural history ofdisease. Various manipulations
thatcanbeaccomplishedinanimalpopulations orbyusing
in vitro studies allow questions to be asked, and some-
timesanswered,thatarenotreadilyamenabletothestudy
ofhuman populations. It is clear from a scientific point of
view, referring to such issues as mechanism, matters of
fiber size, rates of deposition, dissolution, and other
intriguing questions of basic biology, that there is much
thatisyettobelearned.Thisdoesnot,however,inanyway
diminish what is already understood in terms of human
disease patterns, and it should not in any way complicate
what is really a rather simple issue of controlling or
eliminatingexposure to asbestos. Animal studies cantake
placeinbothintactsystemsandininvitromodels,andthe
useofinvitromodelswillevenallowfortheexaminationof
interaction with human tissues.
There are excellent animal data that demonstrate the
inhalation ofbothchrysotileand amphibolefibersproduce
lung cancer and mesothelioma in animals (11). There is
even information available as to the length of time that
such exposure musttakeplace, althoughthisis notalways
wellcorrelatedwithtrue amountsofexposure. Inanimals,
as little as 1 day of exposure appears to be capable of
producing disease, and exposure on the order ofweeks or
months can do so in man aswell; there are even anecdotal
cases of as little as 1 day of heavy exposure in humans
leading to disease many years later. Given the large
amountofhuman datathathas accumulated, thereislittle
that whole animal studies can contribute to the basic
understanding ofthe disease process.
In some ways the possibilities ofvarious cell and tissue
culture models in the study ofthe effects ofasbestos are
more intriguing. Unfortunately, there appears to be wide
variability in responses depending on the system being
studied (12). For some cellular systems, such as hemolysis
testing, there is little variability, but the ultimate useful-
ness of this form of toxicity appears to be limited (13).
Studies of chromosomal aberrations have given widely
differentresultsinthehandsofdifferentinvestigators,but
in some assay systems the irregularity of chromosome
number, as is seen with other carcinogens, has been
documented. Cellular toxicity or lethality as measured by
trypan blue exclusion or radioactive chromium release is
perhaps more stable, but again, of somewhat limited
usefulness. Another often-noted finding, that of nuclear
size alteration and DNA content after exposure to
asbestos, could ultimately be more useful in the develop-
ment of screening tests to study asbestos analogs (i.e.,
other fibers) and perhaps, ultimately, possible asbestos
substitutes.
The use of organ cultures in understanding asbestos-
related mechanistic change has been used by several
investigators, but such work only tends to corroborate in
vitro what has been well documented in vivo, or again
mustbe looked at as apossible testingmechanism for the
screening ofpotential carcinogenic agents (14,15).
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Taken together, the irregularity with which asbestos
can cause any specific change in certain cell systems and
the lack of the "expected" response in tests such as the
bacterial mutagenesis assay system removes many of
these modalities as being potentially useful, either for
mechanistic studies or even for studying human popula-
tions that are exposed to asbestos. Whereas other tech-
niques such as the 32p postlabeling technique may have
some usefulness (16), the use of such laboratory assays
after asbestos exposure is much more problematic. One
may be able to use such tests and indirectly evaluate the
potential effect of asbestos by seeing if a combination of
asbestos and a more "usual" mutagen or carcinogen has
its activity altered by the concomitant administration or
exposure to asbestos.
Patterns of Use and Disease
As noted above, in all groups studied in all countries
wheretherehasbeensignificantpastuseofasbestos,inall
races, and in both occupational and nonoccupational set-
tings, asbestos has produced disease in man. In those
countries with a stronghistoryofasbestos use duringthe
20th century, there is now a clear pattern of diminishing
use or even outright banning. Given the long latency of
asbestos-related disease, this will have little effect in the
short-term, butperhaps in ageneration or two onewillbe
abletomeasuretheeffectofsuchadministrative controlof
exposure.
What can be noted at the present time, however, is the
changingpattern ofasbestos use in theworld. Chrysotile,
the fiber that has been used more than all others com-
bined, is beingused increasingly in countrieswhere there
had been little asbestos use or manufacture. There is a
long history in occupational medicine of disease being
"imported" with the beginning ofindustrial processes or
operations (e.g., dye stuffs, uranium mining, etc.), and it
appears that this pattern is now under way on a global
scale with asbestos.
If the global community were to move, as some coun-
tries have, to reduce or eliminate the use ofasbestos, it is
expected that substitute materials will be suggested for
use. This is in keeping with proper industrial hygiene
principles, andtheuseofsubstitution iswellrecognized as
a method ofreducing potential risk. There maywellbe an
important role formutagenic and carcinogenic studies for
such asbestos substitutes before their introduction into
the human environment. The work of Stanton (17) has
demonstrated the importance of fiber size, regardless of
chemical structure, in the production of malignant dis-
ease, and there maywell be arole forlaboratorymodels in
helping to make assessments about the potential risk of
substitute materials.
Justasthereis aspreadingofthepossibilityofasbestos
exposure, one should also note that as some countries,
among them the United States, are experiencing a reduc-
tion in the use of tobacco products, multinational com-
panies are working diligently to export their tobacco
products into a global market. As increasingly affluent
industrialworkers are able toaffordtobaccoproducts, one
can easily predict that for those workers occupationally
exposed to asbestos, as well as others, the spread of
asbestos exposure and the concomitant spread oftobacco
use will result in a disease development pattern over the
nextdecades andprobablybeyond.Asbestos andexposure
to tobacco smoke are two sources ofexogenous exposure
that individually and synergistically can cause disease in
man, andthese diseaseprocesses areentirelypreventable.
Although it will be necessary to conduct experiments for
manyyears to understand some ofthe nuances ofbiolog-
icalinteractionswithexogenous agentssuchasasbestos, a
fascination with science should not inhibit the scientific
community from intervening to prevent the predictable
disease patterns after exposure to materials such as
asbestos.
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